CN Patent

CN103068982B — 通过抑制盘状大同系物(dlg)的天然反义转录物而治疗dlg相关疾病

Assigned to Opko Curna LLC · Expires 2017-06-09 · 9y expired

What this patent protects

本发明涉及调节盘状大同系物(DLG)的表达和/或功能的反义寡核苷酸，尤其是通过靶向盘状大同系物(DLG)的天然反义多核苷酸。本发明还涉及这些反义寡核苷酸的鉴定和它们在治疗DLG表达相关的疾病和病症中的用途。

USPTO Abstract

本发明涉及调节盘状大同系物(DLG)的表达和/或功能的反义寡核苷酸，尤其是通过靶向盘状大同系物(DLG)的天然反义多核苷酸。本发明还涉及这些反义寡核苷酸的鉴定和它们在治疗DLG表达相关的疾病和病症中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103068982B
Jurisdiction
CN
Classification
—
Expires
2017-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Opko Curna LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.